Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients

NCT02936414 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Berberine
DRUG: Placebo

Sponsor

Tianjin Anding Hospital